Related references
Note: Only part of the references are listed.Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system
Michael F. Salvatore et al.
EXPERIMENTAL NEUROLOGY (2009)
Effective GDNF brain delivery using microspheres-A promising strategy for Parkinson's disease
E. Garbayo et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model
Yin Yang et al.
JOURNAL OF GENE MEDICINE (2009)
Striatal volume differences between non-human and human primates
Dali Yin et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres
E. Garbayo et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Development of a maturing t-cell-mediated immune response in patients with idiopathic parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion
Suzanna M. Tatarewicz et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor
E. Garbayo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal
John T. Slevin et al.
JOURNAL OF NEUROSURGERY (2007)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor
JT Slevin et al.
JOURNAL OF NEUROSURGERY (2005)
Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma:: A randomized phase II trial
P Menei et al.
NEUROSURGERY (2005)
Localized striatal delivery of GDNF as a treatment for Parkinson disease
D Kirik et al.
NATURE NEUROSCIENCE (2004)
Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra
MF Salvatore et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Novel functions and signalling pathways for GDNF
H Sariola et al.
JOURNAL OF CELL SCIENCE (2003)
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
SS Gill et al.
NATURE MEDICINE (2003)
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
JG Nutt et al.
NEUROLOGY (2003)
Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer
B Georgievska et al.
EXPERIMENTAL NEUROLOGY (2002)
Towards a neuroprotective gene therapy for Parkinson's disease:: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model
A Björklund et al.
BRAIN RESEARCH (2000)
Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor
D Kirik et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
